denosumab,zoledronate
amgen,daiichi sankyo
['denosumab', 'ease,(-please),(-disease),(-incrrease),(-decrease)']
spangler et al. no increased risk of mi or stroke in denosumab vs zoledronate in 170,000 patients from optum/marketscan. #acr22 abstr#0575 
Rheumatologist @stjamesdublin , Associate Professor @tcddublin , Acute Medicine, Vasculitis, ILD, Retired @Emeunet Executive Committee member, @rheum_covid CASC